ConSynance Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ConSynance Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11080
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ConSynance Therapeutics Inc (ConSynance Therapeutics), formerly Concerted Therapeutics Inc is a drug discovery company that concentrates on the development of new therapeutic solutions for unmet medical needs. The company provides pipeline programs such as CSTI-100, CSTI-200, and CSTI-300, among others. It develops pipeline programs for nonalcoholic steatohepatitis and inflammatory bowel disease; type-2 diabetes and alzheimer’s disease; irritable bowel syndrome; and CNS diseases, among others. ConSynance Therapeutics offers several preclinical and early development programs in metabolic, autoimmune and digestive, among others. The company works in partnership with other pharma companies for drug development. ConSynance Therapeutics is headquartered in Rensselaer, New York, the US.

ConSynance Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
ConSynance Therapeutics Enters into Research Agreement with Nicholas Barnes 10
ConSynance Therapeutics Enters into Research Agreement with Harvard Medical School 11
Licensing Agreements 12
ConSynance Therapeutics Enters into Licensing Agreement with Albany Medical College 12
ConSynance Therapeutics Inc – Key Competitors 13
ConSynance Therapeutics Inc – Key Employees 14
ConSynance Therapeutics Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
Feb 06, 2017: ConSynance is exploring small leptin mimetics for the treatment Alzheimer’s Disease (AD) 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConSynance Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ConSynance Therapeutics Enters into Research Agreement with Nicholas Barnes 10
ConSynance Therapeutics Enters into Research Agreement with Harvard Medical School 11
ConSynance Therapeutics Enters into Licensing Agreement with Albany Medical College 12
ConSynance Therapeutics Inc, Key Competitors 13
ConSynance Therapeutics Inc, Key Employees 14

List of Figures
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConSynance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[ConSynance Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SUPERVALU INC.:戦略・SWOT・企業財務分析
    SUPERVALU INC. - Strategy, SWOT and Corporate Finance Report Summary SUPERVALU INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Foundation Medicine Inc (FMI):企業の財務・戦略的SWOT分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • PT Central Proteina Prima Tbk (CPRO):企業の財務・戦略的SWOT分析
    PT Central Proteina Prima Tbk (CPRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • STMicroelectronics N.V.:企業の戦略・SWOT・財務分析
    STMicroelectronics N.V. - Strategy, SWOT and Corporate Finance Report Summary STMicroelectronics N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Red Sky Energy Ltd (ROG):石油・ガス:M&Aディール及び事業提携情報
    Summary Red Sky Energy Ltd (Red Sky Energy) is an oil and gas exploration company that explores, develops, and produces oil and coal steam gas. The company’s gas projects comprise Taroom Trough Project and Clarence Moreton project. Its Clarence Moreton project operates a gas reserve position in Wall …
  • Western Area Power Administration:企業の戦略的SWOT分析
    Western Area Power Administration - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Advanced Accelerator Applications SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company’s lead product candidate comprises Lutathera, NETSPOT, SOMAKIT TOC, Gluscan, Gluscan 500, Barnas …
  • Filinvest Development Corporation (FDC):企業の財務・戦略的SWOT分析
    Filinvest Development Corporation (FDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Jumboking Foods Pvt. Ltd.
    Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • IVRCL Ltd:企業の戦略・SWOT・財務情報
    IVRCL Ltd - Strategy, SWOT and Corporate Finance Report Summary IVRCL Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Grohe AG:企業の戦略的SWOT分析
    Grohe AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • WorleyParsons Ltd (WOR):企業の財務・戦略的SWOT分析
    WorleyParsons Ltd (WOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Oracle Corporation Japan (4716):企業の財務・戦略的SWOT分析
    Summary Oracle Corporation Japan (Oracle Corp) is an information technology company that offers software and hardware services. The company offers integrated cloud applications and platform services. It develops software and hardware products, solutions, consulting, support services, education busin …
  • Abu Dhabi Commercial Bank (ADCB):企業の財務・戦略的SWOT分析
    Summary Abu Dhabi Commercial Bank (ADCB) offers traditional and Islamic banking solutions to individuals, high net worth individuals, government, and corporate customers. Its product and service portfolio comprises current and savings accounts; fixed deposits; debit and credit cards; savings and pro …
  • Fluidigm Corp (FLDM)-製薬・医療分野:企業M&A・提携分析
    Summary Fluidigm Corp (Fluidigm) formerly known as Mycometrix Corporation, is a biotechnology company which manufactures life-science tools and creates technologies based on microfluidics and mass cytometry. The company’s products systems include biomark HD system, access array system, C1 system, ca …
  • Disproquima S.A.:企業の戦略・SWOT・財務情報
    Disproquima S.A. - Strategy, SWOT and Corporate Finance Report Summary Disproquima S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Scioderm Inc-製薬・医療分野:企業M&A・提携分析
    Summary Scioderm Inc (Scioderm), a subsidiary of Amicus Therapeutics Inc is a clinical stage biopharmaceutical company that develops various therapies. The company develops novel therapies for conditions including orphan diseases. Its product include Zorblisa (SD-101), is developed for treating the …
  • Esperion Therapeutics Inc (ESPR):企業の財務・戦略的SWOT分析
    Summary Esperion Therapeutics Inc (Esperion), is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). Its …
  • Planung Transport Verkehr AG:企業の戦略的SWOT分析
    Planung Transport Verkehr AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆